Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 NeuroMetrix Issued New U.S. Patent for Quell Wearable Technology - Medical Product Outsourcing
OEM News

NeuroMetrix Issued New U.S. Patent for Quell Wearable Technology

The patent covers core Quell technology that regulates electrical stimulation.

NeuroMetrix Inc. announced that the U.S. Patent and Trademark Office issued the company U.S. Patent No. 10,780,269 titled “Apparatus and Method for Relieving Pain Using Transcutaneous Electrical Nerve Stimulation.”
 
The patent covers core Quell technology that regulates electrical stimulation based on the device orientation.  No other wearable pain relief device has position dependent stimulation control technology that allows the device to automatically modulate treatment based on the user’s body position. This technology is used in Quell’s overnight therapy modes as well for other features.
 
“We are pleased to have received this latest patent, which describes core Quell technology,” said Shai N. Gozani, M.D., Ph.D., president and CEO of NeuroMetrix. “We are continually working to make Quell smarter and more automated so that our customers can focus less on controlling their device and more on enjoying their lives. This patent further establishes Quell as the innovation leader in this area. NeuroMetrix now has 15 issued U.S. utility patents covering Quell technology.”

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters